EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Ion Channels as Therapeutic Targets in Overactive Bladder: A Narrative Review of Mechanisms, Translational Evidence, and Current Gaps

Berkay Demirçi iD, Gülsüm Helvacı iD, Elif Nur Barut iD, Seçkin Engin iD

LUTS: Lower Urinary Tract Symptoms · 2026-07 · 18 (4)

DOI: 10.1111/luts.70080 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift LUTS: Lower Urinary Tract Symptoms, online erschienen am 13.07.2026. Verfasst von Berkay Demirçi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Graduate School of Health Sciences, Karadeniz Technical University, Trabzon, Türkiye. Hauptthemen laut MEDLINE: Urinary Bladder, Overactive, Ion Channels. Die Arbeit nennt 197 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Overactive bladder (OAB) is a prevalent syndrome whose first‐line pharmacotherapy with antimuscarinics and β 3 ‐adrenoceptor agonists is limited by suboptimal efficacy and poor tolerability, underscoring the unmet need for novel molecular targets. As key regulators of detrusor smooth muscle excitability and bladder afferent signaling, ion channels have emerged as a compelling target class capable of modulating bladder function with high spatial precision. This review summarizes current evidence on the role of cation and anion channels in OAB pathophysiology and critically appraises their therapeutic potential, covering the principal channel families implicated in detrusor and afferent dysfunction, including voltage‐gated Ca 2+ and Na + channels, K + channel subfamilies, HCN, TRP, and PIEZO channels, ligand‐gated cation channels, ENaC/ASIC, and Cl − channels, with preclinical and clinical evidence integrated throughout. Despite this strong mechanistic rationale, clinical translation has been hampered by ubiquitous channel expression, patient heterogeneity, and the absence of stratifying biomarkers. Although the supporting evidence remains uneven, spanning genetic, ex vivo, and early‐phase clinical studies, future progress will likely depend on tissue‐selective compounds, biomarker‐defined subphenotypes, and emerging targets such as TMEM16A, TRPM4, and PIEZO channels, which represent particularly promising avenues for next‐generation OAB pharmacotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder, OveractiveIon ChannelsHumansTranslational Research, BiomedicalAnimalsMolecular Targeted Therapy

Stichwörter der Autor:innen

PIEZO channelsTRP channelsdetrusor overactivityion channelsoveractive bladder

Substanzen

Ion Channels

Autor:innen und Institutionen

  • Department of Pharmacology, Graduate School of Health Sciences, Karadeniz Technical University, Trabzon, Türkiye.
  • Department of Pharmacology, Faculty of Pharmacy, Karadeniz Technical University, Trabzon, Türkiye.

ORCID-Profile: Berkay Demirçi, Gülsüm Helvacı, Elif Nur Barut, Seçkin Engin

Zitieren

APA

Demirçi, B., Helvacı, G., Barut, E. N., & Engin, S. (2026). Ion Channels as Therapeutic Targets in Overactive Bladder: A Narrative Review of Mechanisms, Translational Evidence, and Current Gaps. LUTS: Lower Urinary Tract Symptoms, 18(4). https://doi.org/10.1111/luts.70080

Vancouver

Demirçi B, Helvacı G, Barut EN, Engin S. Ion Channels as Therapeutic Targets in Overactive Bladder: A Narrative Review of Mechanisms, Translational Evidence, and Current Gaps. LUTS: Lower Urinary Tract Symptoms. 2026;18(4). doi:10.1111/luts.70080

BibTeX
@article{Demiri2026,
  author = {Demirçi, Berkay and Helvacı, Gülsüm and Barut, Elif Nur and Engin, Seçkin},
  title = {Ion Channels as Therapeutic Targets in Overactive Bladder: A Narrative Review of Mechanisms, Translational Evidence, and Current Gaps},
  journal = {LUTS: Lower Urinary Tract Symptoms},
  year = {2026},
  volume = {18},
  number = {4},
  doi = {10.1111/luts.70080}
}
Kostenlos starten →